Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68 Ga-PSMA PET to mpMRI.

Scheltema MJ, Chang JI, Stricker PD, van Leeuwen PJ, Nguyen QA, Ho B, Delprado W, Lee J, Thompson JE, Cusick T, Spriensma AS, Siriwardana AR, Yuen C, Kooner R, Hruby G, O'Neill G, Emmett L.

BJU Int. 2019 Nov;124 Suppl 1:42-49. doi: 10.1111/bju.14794. Epub 2019 Jul 9.

2.

68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery.

Nandurkar R, van Leeuwen P, Stricker P, Woo H, Kooner R, Yuen C, O'Neill G, Ende D, Cusick T, Ho B, Hickey A, Emmett L.

Br J Radiol. 2019 Mar;92(1095):20180667. doi: 10.1259/bjr.20180667. Epub 2019 Jan 23.

PMID:
30563350
3.

Use of a posterior antiglide plate in a pediatric ankle fracture: a case report.

Fleming JJ, Kooner RK, Soondar S.

J Foot Ankle Surg. 2009 Jul-Aug;48(4):469-73. doi: 10.1053/j.jfas.2009.01.015.

PMID:
19577725
4.

Simple and efficient method for the estimation of residues of flubendiamide and its metabolite desiodo flubendiamide.

Battu RS, Singh B, Kooner R, Singh B.

J Agric Food Chem. 2008 Apr 9;56(7):2299-302. doi: 10.1021/jf073081s. Epub 2008 Mar 6.

PMID:
18321053
5.

Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.

Rasiah KK, Kench JG, Gardiner-Garden M, Biankin AV, Golovsky D, Brenner PC, Kooner R, O'neill GF, Turner JJ, Delprado W, Lee CS, Brown DA, Breit SN, Grygiel JJ, Horvath LG, Stricker PD, Sutherland RL, Henshall SM.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):711-6.

6.

Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.

Horvath LG, Henshall SM, Lee CS, Kench JG, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL.

Int J Cancer. 2005 Jan 20;113(3):415-22.

7.

Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.

Horvath LG, Henshall SM, Kench JG, Turner JJ, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL.

Prostate. 2004 May 15;59(3):234-42.

PMID:
15042598
8.

Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.

Horvath LG, Henshall SM, Kench JG, Saunders DN, Lee CS, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL.

Clin Cancer Res. 2004 Jan 15;10(2):615-25.

9.

Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma.

Rasiah KK, Stricker PD, Haynes AM, Delprado W, Turner JJ, Golovsky D, Brenner PC, Kooner R, O'Neill GF, Grygiel JJ, Sutherland RL, Henshall SM.

Cancer. 2003 Dec 15;98(12):2560-5.

10.

Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.

Henshall SM, Afar DE, Rasiah KK, Horvath LG, Gish K, Caras I, Ramakrishnan V, Wong M, Jeffry U, Kench JG, Quinn DI, Turner JJ, Delprado W, Lee CS, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Mack DH, Sutherland RL.

Oncogene. 2003 Sep 4;22(38):6005-12.

PMID:
12955079
11.

Treatment of localized prostate cancer using a combination of high dose rate Iridium-192 brachytherapy and external beam irradiation: initial Australian experience.

Stevens MJ, Stricker PD, Saalfeld J, Brenner PC, Kooner R, O'Neill GF, Duval PJ, Jagavkar RS, Cross P, Martland J.

Australas Radiol. 2003 Jun;47(2):152-60.

PMID:
12780444
12.

Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.

Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O'Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD.

Cancer. 2003 Apr 15;97(8):1884-93.

13.

Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: implications for staging systems and predictive models.

Quinn DI, Henshall SM, Haynes AM, Brenner PC, Kooner R, Golovsky D, Mathews J, O'Neill GF, Turner JJ, Delprado W, Finlayson JF, Sutherland RL, Grygiel JJ, Stricker PD.

J Clin Oncol. 2001 Aug 15;19(16):3692-705.

PMID:
11504751
14.

Frequent loss of estrogen receptor-beta expression in prostate cancer.

Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL.

Cancer Res. 2001 Jul 15;61(14):5331-5.

15.
16.

Wedge resection of pulmonary metastases from cancer of the testis or kidney using a vascular staple device.

Christmas TJ, Smith GL, Kooner RS.

Br J Urol. 1998 Jun;81(6):911-2. No abstract available.

PMID:
9666781

Supplemental Content

Loading ...
Support Center